Thus, inflammation/CLP/sepsis-induced increases in endogenous levels of epinephrine, glucagon, cortisol, and pro-inflammatory cytokines and treatments such as norepinephrine administration may limit the ability to assess the effects of insulin. This evidence concerns the gene INS and Sepsis.